Veterinary ophthalmology · 2025
Antimicrobial Activity of Ultraviolet C Light as a Potential Novel Treatment for Moraxella bovis Infection-An In Vitro Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Turicea Bactelius, Sahoo Dipak K, Allbaugh Rachel A, Stinman Chloe C, Kubai Melissa A
Аннотация
OBJECTIVE: To investigate the antimicrobial effect of 275 nm wavelength ultraviolet C (UV-C) light on M. bovis using an affordable, broadly available modified handheld device and to determine if photoreactivation plays a role in bacterial resistance to UV-C.
METHODS: UV-C therapy (UVCT) was evaluated in vitro using triplicates of 3 M. bovis isolates from clinical cases. The UVCT was performed at a distance of 10, 15, and 20 mm with 1 or 2 doses (4 h apart) for 5, 15, or 30 s (s); the photoreactivation plates were exposed to 12 h of light at different times (T): T0, T4, T6, and T12 after the treatment.
RESULTS: In vitro results showed all plates treated with UVCT had a 100% bactericidal effect for all the isolates with a single dose of 15 s at a 10 mm distance. At 15 and 20 mm of distance, 2 doses, 4 h apart, were needed for the same effect, or a single dose of 30 s, which had an 88.8% bactericidal effect. No bacterial regrowth was noticed macroscopically after exposure of the treated plates to artificial light at any time point.
CONCLUSIONS: The therapeutic potential for killing M. bovis was confirmed in vitro for all tested isolates using a single exposure of 15 s. UVCT can reduce the need for antibiotics, thereby shortening withdrawal periods for animal-derived food products, having a major impact on the cattle industry. Photoreactivation might not play a role in bacterial resistance to UV-C. While safety studies are underway, clinical trials are warranted.
METHODS: UV-C therapy (UVCT) was evaluated in vitro using triplicates of 3 M. bovis isolates from clinical cases. The UVCT was performed at a distance of 10, 15, and 20 mm with 1 or 2 doses (4 h apart) for 5, 15, or 30 s (s); the photoreactivation plates were exposed to 12 h of light at different times (T): T0, T4, T6, and T12 after the treatment.
RESULTS: In vitro results showed all plates treated with UVCT had a 100% bactericidal effect for all the isolates with a single dose of 15 s at a 10 mm distance. At 15 and 20 mm of distance, 2 doses, 4 h apart, were needed for the same effect, or a single dose of 30 s, which had an 88.8% bactericidal effect. No bacterial regrowth was noticed macroscopically after exposure of the treated plates to artificial light at any time point.
CONCLUSIONS: The therapeutic potential for killing M. bovis was confirmed in vitro for all tested isolates using a single exposure of 15 s. UVCT can reduce the need for antibiotics, thereby shortening withdrawal periods for animal-derived food products, having a major impact on the cattle industry. Photoreactivation might not play a role in bacterial resistance to UV-C. While safety studies are underway, clinical trials are warranted.